Figure 2.

Pharmacokinetics of mipsagargin in plasma after single and multiple intravenous infusions. Samples were collected at multiple timepoints after the first infusion of mipsagargin, 24 h after the second infusion of mipsagargin and 25 days after the third infusion of mipsagargin. The 66.8 mg m⁻² dose is presented as 67 mg m⁻² and the part 2 dosing regimen, 40 mg m⁻² on day 1 and 66.8 mg m⁻² on days 2 and 3, is presented as 40 mg m⁻² with the dotted line.